Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 612

1.

Angiosarcoma of the breast.

Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, Pisters PW, Ballo MT, Chen L, Trent J 3rd, Burgess M, Patel S, Pollock RE, Cormier JN.

Cancer. 2005 Dec 15;104(12):2682-8.

2.

Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic.

Nascimento AF, Raut CP, Fletcher CD.

Am J Surg Pathol. 2008 Dec;32(12):1896-904. doi: 10.1097/PAS.0b013e318176dbc7.

PMID:
18813119
3.

Beyond palliative mastectomy in inflammatory breast cancer--a reassessment of margin status.

Curcio LD, Rupp E, Williams WL, Chu DZ, Clarke K, Odom-Maryon T, Ellenhorn JD, Somlo G, Wagman LD.

Ann Surg Oncol. 1999 Apr-May;6(3):249-54.

PMID:
10340883
4.

Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.

Schuetz F, Diel IJ, Pueschel M, von Holst T, Solomayer EF, Lange S, Sinn P, Bastert G, Sohn C.

Am J Obstet Gynecol. 2007 Apr;196(4):342.e1-9.

PMID:
17403414
5.

A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.

Di Saverio S, Gutierrez J, Avisar E.

Breast Cancer Res Treat. 2008 Oct;111(3):541-7.

PMID:
18026874
6.

Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network.

Bousquet G, Confavreux C, Magné N, de Lara CT, Poortmans P, Senkus E, de Lafontan B, Bolla M, Largillier R, Lagneau E, Kadish S, Lemanski C, Ozsahin M, Belkacémi Y.

Radiother Oncol. 2007 Dec;85(3):355-61.

PMID:
18023492
7.

Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease.

Liauw SL, Benda RK, Morris CG, Mendenhall NP.

Cancer. 2004 Mar 1;100(5):920-8.

8.

The consequence of undertreating breast cancer in the elderly.

Gajdos C, Tartter PI, Bleiweiss IJ, Lopchinsky RA, Bernstein JL.

J Am Coll Surg. 2001 Jun;192(6):698-707.

PMID:
11400963
9.

Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.

Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA.

J Clin Oncol. 2004 Dec 1;22(23):4691-9. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

PMID:
15570071
10.

Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.

Schomas DA, Miller RC, Donohue JH, Gill S, Thurmes PJ, Haddock MG, Quevedo JF, Gunderson LL.

Ann Surg. 2009 Apr;249(4):588-95. doi: 10.1097/SLA.0b013e31819ec7e3.

PMID:
19300231
11.

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

BMC Cancer. 2007 Apr 12;7:63.

12.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Review.

PMID:
17687650
13.
14.

Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in Japan.

Horiguchi J, Iino Y, Koibuchi Y, Yokoe T, Takei H, Yamakawa M, Nakajima T, Oyama T, Ando T, Ishida T, Endo K, Takai Y, Suzuki H, Fujii T, Yokomori T, Morishita Y.

Breast Cancer. 2002;9(2):160-5.

PMID:
12016396
15.

Clinical features and prognostic factors of early breast cancer at a major cancer center in North India.

Raina V, Bhutani M, Bedi R, Sharma A, Deo SV, Shukla NK, Mohanti BK, Rath GK.

Indian J Cancer. 2005 Jan-Mar;42(1):40-5.

16.

The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study.

Stemmer SM, Rizel S, Hardan I, Adamo A, Neumann A, Goffman J, Brenner HJ, Pfeffer MR.

J Clin Oncol. 2003 Jul 15;21(14):2713-8.

PMID:
12860949
17.

Neoadjuvant chemotherapy in stage III breast cancer.

Alassas M, Chu Q, Burton G, Ampil F, Mizell J, Li BD.

Am Surg. 2005 Jun;71(6):487-92.

PMID:
16044927
18.

Angiosarcoma of the breast: a difficult surgical challenge.

Hui A, Henderson M, Speakman D, Skandarajah A.

Breast. 2012 Aug;21(4):584-9. doi: 10.1016/j.breast.2012.01.001.

PMID:
22305554
19.

Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.

D'Alessandro C, Dellapasqua S, Orlando L, Santoro L, Maisonneuve P, Torrisi R, Balduzzi A, Scarano E, Ghisini R, Peruzzotti G, Goldhirsch A, Colleoni M.

Breast J. 2008 Sep-Oct;14(5):435-41. doi: 10.1111/j.1524-4741.2008.00619.x.

PMID:
18821931
20.

Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.

Hébert-Croteau N, Brisson J, Lemaire J, Latreille J, Pineault R.

Cancer. 2005 Oct 1;104(7):1343-8.

Items per page

Supplemental Content

Support Center